John W Smither Genelux Corp (GNLX) insider trading activity

Shares Held (Direct Ownership) 52.7K

300.24% 3M change

661.72% 12M change

Total Value Held N/A

John W Smither Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 01 2024	BUY Grant, award, or other acquisition	-	39,541 Added 42.86%	52,711 Common Stock
May 29 2024	BUY Open market or private purchase	-	6,250 Added 32.18%	13,170 Common Stock
Sep 13 2023	SELL Open market or private sale	$18,702 $20.78 p/Share	900 Reduced 11.51%	6,920 Common Stock
Sep 11 2023	BUY Grant, award, or other acquisition	-	6,920 Added 46.95%	7,820 Common Stock

ARQT

Arcutis Biotherapeutics, Inc. Healthcare

Chief Financial Officer

EFTR

eFFECTOR Therapeutics, Inc. Healthcare

Director

AMTI

Applied Molecular Transport Inc. Healthcare

Director

NAMS

NewAmsterdam Pharma Co N.V.

JWS

Solana Beach, CA

Receive a notification when an Institution or Guru buys or sells GNLX shares.

Notify only if

Value

Get notified when an Genelux Corp insider buys or sells GNLX shares.

Notify only if

Operation

Value

Type

Receive news related to GENELUX CORP